Bacterial resistance--the clinical challenge - PubMed (original) (raw)
Review
. 2002:8 Suppl 3:21-32; discussion 33-5.
doi: 10.1046/j.1469-0691.8.s.3.3.x.
Affiliations
- PMID: 12519346
- DOI: 10.1046/j.1469-0691.8.s.3.3.x
Free article
Review
Bacterial resistance--the clinical challenge
R Finch. Clin Microbiol Infect. 2002.
Free article
Abstract
Resistance to antibacterial agents has increased among many species of bacterial pathogens in the last two decades. While this has been recognized and has been a matter of concern among those concerned with infectious diseases, it is only relatively recently that prescribing physicians have become aware of the problem. A range of official bodies, both national and international, have proposed a range of strategies for controlling this increase in resistance. The relationship between resistance and clinical efficacy or failure is unclear in many areas, although increasingly resistance can be seen to be associated with a less than optimal clinical response. Although the relationship between antibiotic use and resistance is complex, there is an assumption that excessive use of antibacterials may drive an increase in resistance. The term 'prudent prescribing' is frequently used in official documents, but it is not easy for the prescriber to determine exactly what is prudent prescribing. There have been efforts to reduce the unnecessary use of antibacterials in the treatment of many community respiratory infections where the etiological agent is likely to be viral. Guidelines for prescribing have been drawn up by governments and professional societies but their impact can be variable. They need to take account of the changing patterns of resistance, for example the rise in high-level penicillin resistance among pneumococci. They also need to be readily accessible to the practicing clinician. Surveillance systems are available in abundance and these may be local, national, or international. They often, however, suffer from drawbacks and are frequently selective. Frequently the prescriber does not have ready access to the most appropriate data. Integrated strategies to control resistance are urgently needed, as are improved rapid diagnostic facilities.
Similar articles
- Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.
Finch R, Hunter PA. Finch R, et al. J Antimicrob Chemother. 2006 Sep;58 Suppl 1:i3-i22. doi: 10.1093/jac/dkl373. Epub 2006 Sep 26. J Antimicrob Chemother. 2006. PMID: 17003063 - Antibiotic resistance: a view from the prescriber.
Finch RG. Finch RG. Nat Rev Microbiol. 2004 Dec;2(12):989-94. doi: 10.1038/nrmicro1049. Nat Rev Microbiol. 2004. PMID: 15550945 Review. - Optimising antibiotic prescribing in primary care.
McNulty CA. McNulty CA. Int J Antimicrob Agents. 2001 Oct;18(4):329-33. doi: 10.1016/s0924-8579(01)00412-5. Int J Antimicrob Agents. 2001. PMID: 11691564 Review. - [Antibiotic resistance : situation in Europe and Switzerland, and impact for the physician].
Bellini C, Troilet N. Bellini C, et al. Rev Med Suisse. 2016 Oct 12;12(534):1699-1702. Rev Med Suisse. 2016. PMID: 28686394 French. - Factors contributing to excessive antimicrobial prescribing.
Ebert SC. Ebert SC. Pharmacotherapy. 2007 Oct;27(10 Pt 2):126S-130S. doi: 10.1592/phco.27.10part2.126S. Pharmacotherapy. 2007. PMID: 17896905
Cited by
- Diagnosing infections: a qualitative view on prescription decisions in general practice over time.
Björnsdóttir I, Kristinsson KG, Hansen EH. Björnsdóttir I, et al. Pharm World Sci. 2010 Dec;32(6):805-14. doi: 10.1007/s11096-010-9441-6. Epub 2010 Oct 8. Pharm World Sci. 2010. PMID: 20931359 - [Community-acquired and nosocomial pneumonia].
Welte T. Welte T. Internist (Berl). 2003 Jun;44 Suppl 1:S44-58. doi: 10.1007/s00108-003-0964-y. Internist (Berl). 2003. PMID: 14567088 German. - The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target.
Mazumdar K, Dastidar SG, Park JH, Dutta NK. Mazumdar K, et al. Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):881-91. doi: 10.1007/s10096-009-0739-z. Epub 2009 Apr 28. Eur J Clin Microbiol Infect Dis. 2009. PMID: 19399540 Review. - Nanomedicine as an emerging approach against intracellular pathogens.
Armstead AL, Li B. Armstead AL, et al. Int J Nanomedicine. 2011;6:3281-93. doi: 10.2147/IJN.S27285. Epub 2011 Dec 9. Int J Nanomedicine. 2011. PMID: 22228996 Free PMC article. Review. - In vivo noninvasive microscopy of human leucocytes.
Winer MM, Zeidan A, Yeheskely-Hayon D, Golan L, Minai L, Dann EJ, Yelin D. Winer MM, et al. Sci Rep. 2017 Oct 12;7(1):13031. doi: 10.1038/s41598-017-13555-1. Sci Rep. 2017. PMID: 29026161 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical